deuterium oxide has been researched along with levodopa in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dischia, M; Manini, P; Prota, G | 1 |
| Azulay, JP; Balduyck, S; Blin, O; Brefel-Courbon, C; Durif, F; Esquerre, JP; Ory-Magne, F; Payoux, P; Rascol, O; Regragui, W; Thalamas, C; Tison, F | 1 |
| Dhawan, V; Eidelberg, D; Ko, JH; Ma, Y; Mure, H; Spetsieris, P; Tang, CC | 1 |
3 other study(ies) available for deuterium oxide and levodopa
| Article | Year |
|---|---|
Pictet-Spengler condensation of the antiparkinsonian drug L-DOPA with D-glyceraldehyde. Opposite kinetic effects of Fe3+ and Cu2+ ions and possible implications for the origin of therapeutic side effects.
Topics: Aldehydes; Antiparkinson Agents; Chelating Agents; Chromatography, High Pressure Liquid; Copper; Deuterium Oxide; Glyceraldehyde; Iron; Kinetics; Levodopa; Models, Molecular; Molecular Conformation; Spectrophotometry, Ultraviolet | 2001 |
Motor activation in multiple system atrophy and Parkinson disease: a PET study.
Topics: Aged; Brain Mapping; Case-Control Studies; Deuterium Oxide; Dopamine Agents; Functional Laterality; Hand; Humans; Levodopa; Motor Cortex; Movement; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Statistics, Nonparametric | 2010 |
Parkinson's disease: increased motor network activity in the absence of movement.
Topics: Aged; Antiparkinson Agents; Brain; Brain Mapping; Cerebrovascular Circulation; Cohort Studies; Deep Brain Stimulation; Deuterium Oxide; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Subthalamic Nucleus | 2013 |